2000ManBioTech's profile picture.

2000Man

@2000ManBioTech

Oculis $OCS I am not sure what Roche and Novartis are waiting for. Company has three successful small Phase 2 trials which are de risked to work in larger Phase3s. In two multi billion eye disease areas - DME and dry eye - plus rare optic neuro asset that can work in MS!


2000Man รีโพสต์แล้ว

Why must we all agree that we’ve reached the end of days for biomedical innovation? That’s indeed what we disagree on. It’s what people thought 20 years ago and many times since. Every time market drops, someone assumes it’s the end. Always wrong to bet against progress.


Loading...

Something went wrong.


Something went wrong.